Evidence map›Paper›PMID 35925317›Full record

ReviewPathologie (Heidelberg, Germany)2022

[Accreditation in pathology and neuropathology : Paths and pitfalls].

K Holl-Ulrich, C Hagel, G Köhler, C Flechtenmacher

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pathologie (Heidelberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

K Holl-UlrichPathologie - Hamburg, Labor Lademannbogen MVZ GmbH, 22339, Hamburg, Deutschland. holl-ulrich@pathologie-hamburg.de.
C HagelInstitut für Neuropathologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland.
G KöhlerInstitut für Pathologie, Klinikum Fulda gAG, Fulda, Deutschland.
C FlechtenmacherPathologisches Institut, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are many good reasons for accreditation in pathology or neuropathology as per DIN EN ISO/IEC 17020, regardless of the size and range of services of the facility. Only accreditation - in contrast to certification - also confirms professional competence. This article describes how to establish a quality management system that conforms to standards as effectively as possible and how to maintain it, involve staff, and avoid common pitfalls. Adequate resources and active management support are essential. In this way, not only can accreditation succeed, but the facility itself and its employees can benefit from quality management in their daily work.

Indexed as

AccreditationCertificationHumansNeuropathologyProfessional CompetenceCertificationDiagnostic reagent kitsLaboratoriesQuality improvementTotal quality management

Identifiers

PMID35925317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.